Jill Henrich, EVP, Global Head RA & Quality at Atara Biotherapeutics, Inc. (ATRA), sold 3,346 shares at $1.65 ($6K) on 2023-08-16, disclosed to the SEC on 2023-08-18.
Open-market sale of $6k ATRA by EVP, Global Head RA & Quality. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.65 | 558 | $921 | 16.7% |
| 2 | $1.65 | 2,788 | $5K | 83.3% |
| Total | $1.65 avg | 3,346 | $6K | 100% |
| Filing → |
| ATRA | SELL | 2024-08-20 | $6K | — | Filing → |
| ATRA | SELL | 2024-05-20 | $16K | — | Filing → |
| ATRA | SELL | 2024-03-06 | $3K | — | Filing → |